“Astronomy is an entirely observational science — we cannot do an experiment or make physical measurements. So we have to simulate what we observe with computers."
As a cancer prevention researcher trained in both basic laboratory science and epidemiology, Kuhs’ experience allows her to apply basic science findings to population-based studies, which will be essential to lowering cancer rates in the hardest-hit areas of the state.
"Our outstanding researchers at the University of Kentucky are leading the way in translational chemical biology, and the recently awarded COBRE grant is a testament to UK CPRI’s success in their constant pursuit of discovery," said UK President Eli Capilouto.
UK researchers hope to gain a better understanding of the effects of COVID-19 on sleep and alcohol use so that we will be better prepared to prevent and treat psychological effects of COVID-19 pandemic or similar outbreaks in the future.
Nearly all Martin County survey respondents reported problems with their drinking water including odor, appearance, taste and pressure. The UK researchers found 47% of the samples had at least one contaminant that exceeded U.S. EPA regulatory guidelines.
Researchers will be looking at a medication that recently received experimental approval from the USDA and its impact on the newly characterized form of dementia known as LATE. LATE is a disease with symptoms similar to Alzheimer’s disease.
For the past several decades, much of the work to find a treatment for AD has been focused on eliminating those dreaded Aβ plaques, by assuming that memory could be restored by removing the plaques.
Kentucky has one of the nation's highest incidences of oral cancer, according to the National Institutes of Health, and the prevalence of oral cancer in the targeted counties is as much as 54% higher than the state average.
“We all want to grow Kentucky’s tech sector and create the high-paying, knowledge-based jobs that follow. A big part of doing so is turning Kentucky’s own academic research and development capabilities into commercially viable products and startups.”
KYNETIC, funded by the National Institutes of Health (NIH), is excited to announce that five of the seven projects recently awarded $50,000 to bring their innovations toward product development are from the University of Kentucky.
